| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43ae37d4a0d7b3ba3039be45c22fecb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c3a66c15567a95a79d896fc60b2ee3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b4f413179eb46af63bfbb5040cf72cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34a1e975c4062d3fdc16c8bb9e0b2d33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39ad4d45156a3626f2d61844e39b671a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3233 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2008-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea48208e79971ad1289393fd580e6557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_155e31e71a24f2c12433370cbcdf8d33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ca5c533d311bb3ce3aef0f65bf71620
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70af74183e9551e742af4c1a5dd24d38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1185d6634de022fa135e771c3846e16 |
| publicationDate |
2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013160150-A1 |
| titleOfInvention |
Methods for identifying compounds that modulate lisch-like protein or c1orf32 protein activity and methods of use |
| abstract |
The invention provides methods for reducing diabetes susceptibility in a subject and methods for increasing the expression of LL or CLORF32 in a subject. The invention further provides a method for identifying an agent which modulates expression of an Ll RNA or Clorf32 RNA comprising contacting a cell with an agent; determining expression of the Ll RNA or Clorf32 RNA in the presence and the absence of the agent; and comparing expression of the Ll RNA or Clorf32 RNA in the presence and the absence of the agent, wherein a change in the expression of the Ll RNA or Clorf32 RNA in the presence of the agent is indicative of an agent which modulates the level of expression of the RNA. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9617336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9555087-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9428574-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9375466-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9107862-B2 |
| priorityDate |
2007-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |